Qvella Corporation

Biotechnology, Health Care, Health Diagnostics, Medical Device
Founded in 1/1/09
Richmond Hill, Ontario, Canada
http://www.qvella.com/
For Profit

About Qvella Corporation

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: None
  • Tech Stack: 22 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 45399000 USD
  • Last Funding: None (Venture - Series Unknown)
  • Funding Status:

Technology Stack

Qvella Corporation actively uses 22 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Health Diagnostics, Medical Device

Headquarters: Richmond Hill, Ontario, Canada

Employees

  • David Haake - Chief Medical Officer (LinkedIn)
  • Michelle Truong - Human Resources Business Partner (LinkedIn)
  • Richard Brock - Chief Commercial Officer (CCO) (LinkedIn)